Search - tctmd.com

Displaying 181 - 200 of 457

Sort: Relevancy | Date

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

Presentation TCT 2014

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Matthew J. Price

September 14, 2014

Presentation TCT 2014

Time to Move to 3-6 Months Even in ACS!

Presenter: Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Definitely Not the Data are Clear!

Presenter: Germano Di Sciascio

September 14, 2014

Presentation TCT 2014

Definitely the Data are Clear!

Presenter: E. Magnus Ohman

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

Case #3. Multivessel Disease in a Stable CAD Patient

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Daily News

非临床因素对检查出CAD有着较大的影响

Yael L. Maxwell

September 13, 2014

News Daily News

Nonclinical Factors Substantially Affect Detection of Obstructive CAD

Yael L. Maxwell

September 13, 2014

News Daily News

Los Factores No Clínicos Influyen Significativamente en la Detección de la EAC Obstructiva

Yael L. Maxwell

September 13, 2014

Presentation

Impact of the System and Physician Factors on the Detection of Obstructive CAD with Diagnostic Angiography in Stable Ischemic Heart Disease

Presenter: Harindra C. Wijeysundera

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Daily News

Pre-Angiography Symptom Assessment, Shared Decision Making Key to Improving PCI Appropriateness

Yael L. Maxwell

September 02, 2014

Advertisement

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Keynote Address Focuses on Newer DES, Problematic Subgroups

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Time to Move to 3-6 Months Even in ACS!

Definitely Not the Data are Clear!

Definitely the Data are Clear!

The Data Strongly Support Heparin!

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Case #3. Multivessel Disease in a Stable CAD Patient

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

非临床因素对检查出CAD有着较大的影响

Nonclinical Factors Substantially Affect Detection of Obstructive CAD

Los Factores No Clínicos Influyen Significativamente en la Detección de la EAC Obstructiva

Impact of the System and Physician Factors on the Detection of Obstructive CAD with Diagnostic Angiography in Stable Ischemic Heart Disease

European Societies Release Updated Revascularization Guidelines for CAD

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

Pre-Angiography Symptom Assessment, Shared Decision Making Key to Improving PCI Appropriateness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content